TY - JOUR T1 - Evaluating the suitability of the case-crossover design under changing baseline outcome risk: A simulation of ambient temperature and preterm birth JF - medRxiv DO - 10.1101/2021.02.17.21251948 SP - 2021.02.17.21251948 AU - Daniel Carrión AU - Johnathan Rush AU - Elena Colicino AU - Allan C. Just Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/02/19/2021.02.17.21251948.abstract N2 - Case-crossover (CCO) studies are case-only within-person analyses of associations between acute exposures and outcomes. By design, the CCO is not confounded by time-invariant characteristics. CCO studies assume stable baseline outcome risks. Since the baseline risk of birth increases secularly over gestation, the validity of CCOs of preterm birth (PTB) is not clear. We simulated associations between temperature and PTB in New York State using historical ambient temperature data for LaGuardia Airport and PTB data from the CDC using different control period durations. CCO analyses were conducted with conditional logistic regression. We calculated bias according to the absolute difference between the simulated and estimated effects in the natural log scale and found that 1-month stratified control period selection yielded bias away from the null across all simulated effects (median = 0.018, IQR: 0.010 − 0.026). In contrast, the 2-week stratification resulted in negligible bias (median: 0.001, IQR: −0.011 − 0.012). Coverage of the 95% confidence intervals decreased with higher effects for the 1-month stratification, with a range 17-87% of estimated intervals including the simulated effect. 2-week stratification had consistent coverage across models (range 95-96%). Our findings suggest that future studies should consider using shorter time strata for PTB.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by NIH grant P30ES023515. DC is funded by NIH T32HD049311.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This is not human subjects research. Data are publicly-available and not identifiable.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data and analytical code to reproduce results are available on GitHub. https://github.com/justlab/casecrossover_preterm_simulation ER -